6-amino-4-(pyrimidin-4-yl)pyridones: novel glycogen synthase kinase-3β inhibitors
Coffman, K., Brodney, M., Cook, J., Lanyon, L., Pandit, J., Sakya, S., Schachter, J., Tseng-Lovering, E., Wessel, M.(2011) Bioorg Med Chem Lett 21: 1429-1433
- PubMed: 21295469 
- DOI: https://doi.org/10.1016/j.bmcl.2011.01.017
- Primary Citation of Related Structures:  
3Q3B - PubMed Abstract: 
The synthesis and structure-activity relationships for a novel series of 6-amino-4-(pyrimidin-4-yl)pyridones derived from a high throughput screening hit are discussed. Optimization of lead matter afforded compounds with good potency, selectivity and central nervous system (CNS) exposure.
Organizational Affiliation: 
Pfizer Global Research and Development, Groton Laboratories, Groton, CT 06340, USA. karen.j.coffman@pfizer.com